These findings suggest that Akt2 signaling induces prompt cytotoxicity in CTLs, allowing them to penetrate the tumor core, while Akt1 signaling in CTLs enhances delayed cytotoxicity in CTLs that remain in the stroma and the liver, leading to non-specific liver damage. This evidence concerns the gene AKT1 and neoplasm.